TORONTO, Aug. 11, 2020 /PRNewswire/ – Canadian startup company Future Fertility has commercially launched a product that is providing a new solution in the field of Assisted Reproductive Technology (ART). Their newly marketed product Violet™ is a cloud-based software that assesses the probability of an oocyte (human egg) to successfully fertilize and reach a blastocyst embryo stage. Violet™, an AI-based image technology that has been optimized through scientific collaborations with several In-Vitro Fertilization (IVF) clinics around the world, analyzes 2-D images of a patient’s eggs in real-time. Until now, there has been no accepted method to visually grade an egg or predict its reproductive potential.
